The invention provides human cyclic nucleotide phosphodiesterases
(HSPDE10A) and polynucleotides which identify and encode HSPDE10A. The
invention also provides expression vectors, host cells, antibodies,
agonists, and antagonists. The invention also provides methods for
diagnosing, treating, or preventing disorders associated with expression
of HSPDE10A.